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Abstract
Copyright © Experimental Oncology, 2015. Background: Colorectal, lung and breast tumors are
the most devastating and frequent malignances in clinical oncology. SEREX-analysis of colon
cancer leads to identification of more than hundred antigens which are potential tumor markers.
With idea that immunoscreening with pool of allogeneic sera is more productive for antigen
isolation, SEREX-analysis was applied to four cases of stages II-IV primary colon tumor and 22
new antigens  were  isolated.  Objective:  To  characterize  22  primary  colon  cancer  antigens
isolated by SEREXtechnique. Materials and Methods: Allogenic screening, real-time PCR analysis.
Results: After allogeneic immunoscreening, for 5 of 22 (22%) isolated antigens were confirmed
colon cancer restricted serological profile solely positive for 14% of tested colon cancer sera.
Through these five antigens, KY-CC-17/β-actin has cytoskeleton function; KY-CC-14/ACTR1A and
KY-CC-19/TSGA2  participate  in  chromosome segregation;  KY-CC-12/FKBP4  regulates  steroid
receptor function and KY-CC-15/PLRG1 is a component of spliceosome complex. For the last four
antigens  tested  were  found  aberrant  mRNA  expression  in  some  cases  of  colon  tumor.
Conclusion:  The  exploration  of  identified  antigens  may  define  suitable  targets  for
immunotherapy  or  diagnostic  of  colon  cancer.
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